Home | American Botanical Drug Association First FullSpectrum Cannabinoid Drug Seeking FDA Approval to Treat ASD Chiesi Global Rare Diseases Announces FDA Approval of FILSUVEZ for Epidermolysis Bullosa Wounds ABDA Partnership Launches Digital HPLC Database to Elevate Botanical Drug Standards FDA Approves NexoBrid a Revolutionary Topical Gel for Burn Care Botanical Drug for the Treatment of Alopecia Areata in Children Botanical drug clinical trial common issues and future options Over the past decade the Botanical Analytic Laboratory has amassed a vast collection of herbs from around the globe and followed the process below to create a repository bank of botanical ingredients Dividing each herb into 4 to 8 segments. Conducting HPLC HighPerformance Liquid Chromatography analyses on these segments to identify and isolate specific compound. Storing each isolated ingredient in a vial and precisely regulating the temperature to ensure preservation. Thebotanical reference standardsrepository bank holds over 10000 botanical ingredient standards witheach precisely dosed at 20mg in vials and boasting a purity of HPLC98.